S&P 500
$5,842.01
-0.0%
-$2.60
DJI
$41,859.09
-0.0%
-$1.35
NASDAQ
$18,925.73
+0.3%
+$53.09
Bitcoin
110,874.00
+0.2%
+176.90
AAPL
$201.16
-0.5%
-$0.93
AMZN
$202.96
+0.9%
+$1.84
GOOG
$171.96
+1.1%
+$1.90
META
$636.81
+0.2%
+$1.31
MSFT
$454.60
+0.4%
+$2.03
NVDA
$132.90
+0.8%
+$1.10
TSLA
$341.59
+2.1%
+$6.97
Zeo ScientifiX (OTC: BPSR)
$1.97
(-1.0%)
-$0.02
Price as of May 22, 2025, 1:39 p.m. ET
Zeo ScientifiX Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zeo ScientifiX Company Info
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of degenerative diseases. Its product is Zofin, which is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Davie, FL.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.